Ā | Total cohort1 (nĀ =ā829) | HCW (nĀ =ā546; 65.9%) | NHCW (nĀ =ā283; 34.1%) | p-value2 |
---|---|---|---|---|
Demographics | ||||
āSex | Ā | Ā | Ā | 0.30 |
āāMale | 298 (35.9%) | 191 (35.0%) | 107 (37.8%) | Ā |
āāFemale | 531 (64.1%) | 355 (65.0%) | 176 (62.2%) | Ā |
āAge (years) | Ā | Ā | Ā | 0.001 |
āā20ā39 | 428 (51.6%) | 300 (55.0%) | 128 (45.2%) | Ā |
āā40ā59 | 315 (38.0%) | 204 (37.4%) | 111 (39.2%) | Ā |
āāā„ā60 | 86 (10.4%) | 42 (7.7%) | 44 (15.6%) | Ā |
āRace | Ā | Ā | Ā | <ā0.001 |
āāWhite | 483 (58.3%) | 285 (52.2%) | 198 (70.0%) | Ā |
āāAsian | 170 (20.5%) | 131 (24.2%) | 39 (13.8%) | Ā |
āāBlack | 90 (10.9%) | 70 (12.8%) | 20 (7.1%) | Ā |
āāOther/missing | 86 (10.4%) | 60 (1%) | 26 (9.2%) | Ā |
Hispanic ethnicity | 101 (12.2%) | 68 (12.5%) | 33 (11.7%) | 0.74 |
Current smoker | 37 (4.5%) | 19 (3.5%) | 18 (6.4%) | 0.001 |
Social distancing | ||||
āWorked on-site (at hospital and/or university) in prior week | 734 (88.5%) | 530 (97.1%) | 204 (72.1%) | <ā0.001 |
āStayed home as much as possible when not working | 691 (83.9%) | 461 (84.9%) | 230 (81.9%) | 0.25 |
āAvoided being around other people as much as possible | 702 (85.4%) | 467 (86.3%) | 235 (83.6%) | 0.34 |
āRecent exposure outside of work to someone with COVID-19 or new fever, cough, or shortness of breath | 88 (10.7%) | 68 (12.6%) | 20 (7.1%) | 0.02 |
Clinical characteristics | ||||
āAny chronic comorbidity3 | 288 (34.7%) | 184 (33.7%) | 104 (36.8%) | 0.38 |
āāDiabetes mellitus | 48 (5.9%) | 34 (6.3%) | 14 (5.0%) | 0.44 |
āāHypertension | 125 (15.2%) | 80 (14.9%) | 45 (15.9%) | 0.68 |
āāCoronary or cerebrovascular disease or heart failure | 20 (2.4%) | 15 (2.8%) | 5 (1.8%) | 0.38 |
āāAsthma, COPD, or other chronic lung disease | 113 (13.6%) | 73 (13.4%) | 40 (14.2%) | 0.76 |
āāAutoimmune disease or reported immunosuppressant use | 40 (4.9%) | 28 (5.2%) | 12 (4.2%) | 0.57 |
āāCOVID-19 symptoms in last week (any)4 | 98 (11.9%) | 76 (13.9%) | 22 (7.8%) | 0.02 |